Transition from milk to solid food reshapes gut microbes, triggering epigenetic changes in intestinal stem cells that create lasting immune memory, strengthening responses, and reducing disease risk ...
As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...
India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for ...
Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed. For years, mitochondrial ...
Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them ...
Silicon nanotube arrays deliver functional mRNA into human pluripotent stem cells for the first time, achieving up to 64% transfection without compromising stem cell identity.
Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...
Japan's approval of the world’s first medical treatments using reprogrammed human cells signals a new era in regenerative ...